1. $ANTH looks like we re seeing some pretty strong resistance around this mark.

  2. $ZIOP $CRIS $ACRX $MACK $MNKD $ALIM $AVNR $ANTH $SNTA $KERX $RMTI -- loving this market, so much opportunity, not enough money

  3. $ANTH plan to conduct interim analysis to determine the effect of blisibimod on proteinuria after 8 wks of treatment in 2nd half of 2014

  4. @mattig Should be soon, $ANTH, expect in Q3 or Q4.

  5. @Glopolon Does anyone have any idea when $ANTH will be releasing interim data? It s been almost a month since the expected data release date

  6. @mattig $ANTH BRIGHT-SC Phase 2 needs positive update to give strength to PPS.

  7. @mattig $ANTH Yeah, it would be great to get a partner. I think people are holding off now waiting for answer to cash need to run trials.

  8. @Glopolon $BMY could b ideal partner 4 A-623 +upside as Benlysta sales continue increase. But as $ burns the negot. position 4 $ANTH weakens

  9. $ANTH Where you d like a partner to reduce cash burn.

  10. $ANTH Cash and cash burn questions need to be answered.

  11. $ANTH Anthera Pharmaceuticals Reports 2014 Second Quarter Financial Results and Operational Update.. http://y.ahoo.it/we67JoEU

  12. When is $Anth going to get around to making an actual announcement?

  13. $ANTH in 3.04

  14. $OPK $EDAP $SNTA $ANTH stalking...

  15. $ANTH looks attractive fora buy around here

  16. @jungle79 $ANTH - IF it goes back under $3 ;)

  17. $anth Will buy when it goes under $3

  18. $ANTH Are we heading back below 2.80? That would seem to be terribly premature...

  19. Time to recover after yesterday s crash $gluu $meet $plug $aezs $anth $fb $isr $pgnx

  20. $CYTX if Janet Yellen told your portfolio to jump off a cliff would it? $PPHM $RNN $ALXA $ANTH

  21. $ANTH Anthera Pharmaceuticals Inc files Form 8-K (Events or Changes Between Quarterly Reports) SEC Fil.. http://y.ahoo.it/1lF4IFam

  22. Anthera Pharmaceuticals just filed its Current report, items 1.01 and 9.01 http://y.ahoo.it/sO8ZbcLs $ANTH

  23. $ANTH Anthera Pharmaceuticals Inc. (NASDAQ:ANTH): Acquires Sollpura® From Eli Lilly and Company http://y.ahoo.it/Cj7i8gK4

  24. Anthera Pharmaceuticals upgraded by Zacks to outperform. $3.60 PT. http://y.ahoo.it/28EFHK8C $ANTH

  25. $ANTH, $CBMX, $GLUU, $YGE, $LJPC, $PLUG, $ICLD, $EJ, $CDXS gl traders